Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Modulation of amyloid β protein precursor processing as a means of retarding progression of Alzheimer’s disease
Steven L. Wagner, Benito Munoz
Steven L. Wagner, Benito Munoz
Published November 15, 1999
Citation Information: J Clin Invest. 1999;104(10):1329-1332. https://doi.org/10.1172/JCI8729.
View: Text | PDF
Perspective Article has an altmetric score of 3

Modulation of amyloid β protein precursor processing as a means of retarding progression of Alzheimer’s disease

  • Text
  • PDF
Abstract

Authors

Steven L. Wagner, Benito Munoz

×

Total citations by year

Year: 2018 2016 2013 2011 2010 2006 2005 2001 2000 Total
Citations: 1 1 2 1 1 1 1 2 3 13
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (13)

Title and authors Publication Year
A peptide–WS 2 nanosheet based biosensing platform for determination of β-secretase and screening of its inhibitors
X Zuo, H Dai, H Zhang, J Liu, S Ma, X Chen
The Analyst 2018
Relationship between the polymorphism in exon 5 of BACE1 gene and Alzheimer’s disease
M Wang, J Yang, J Su
Aging clinical and experimental research 2016
Sensitive and Continuous Screening of Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) at Single SPR Chips
X Yi, Y Hao, N Xia, J Wang, M Quintero, D Li, F Zhou
Analytical Chemistry 2013
Amplified voltammetric characterization of cleavage of the biotinylated peptide by BACE1 and screening of BACE1 inhibitors
X Yi, H Han, Y Zhang, J Wang, Y Zhang, F Zhou
Biosensors and Bioelectronics 2013
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee
Annual Reports in Medicinal Chemistry Volume 46 2011
Modulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease
MZ Kounnas, AM Danks, S Cheng, C Tyree, E Ackerman, X Zhang, K Ahn, P Nguyen, D Comer, L Mao, C Yu, D Pleynet, PJ Digregorio, G Velicelebi, KA Stauderman, WT Comer, WC Mobley, YM Li, SS Sisodia, RE Tanzi, SL Wagner
Neuron 2010
Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease
B Wang, F Jin, Y Xie, Y Tang, R Kan, C Zheng, Z Yang, L Wang
Neuroscience Letters 2006
Genetic Association of BACE1 Gene Polymorphism C786G With Late-Onset Alzheimer's Disease in Chinese
R Kan, B Wang, C Zhang, F Jin, Z Yang, S Ji, Z Lu, C Zheng, L Wang
Journal of Molecular Neuroscience 2005
Amyloid Precursor Protein and Amyloid β Peptide in Human Platelets: ROLE OF CYCLOOXYGENASE AND PROTEIN KINASE C
DM Skovronsky, VM Lee, D Praticò
The Journal of biological chemistry 2001
Amyloid beta peptide processing, insulin degrading enzyme, and butyrylcholinesterase
A S Balasubramanian
Neurochemical Research 2001
Therapeutic approaches to Alzheimer’s disease
ED Thorsett, LH Latimer
Current Opinion in Chemical Biology 2000
Aβ Modulation: The Next Generation of AD Therapeutics
KM Felsenstein
Annals of the New York Academy of Sciences 2000
Advances in Dementia Research
K Jellinger, R Schmidt, M Windisch
2000

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 12 patents
11 readers on Mendeley
See more details